Analyst Ratings for Reata Pharmaceuticals (RETA)

RETA Rating Summary

  |   Expand Research on RETA
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4.3 / 10   Percentile Rank: 43%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/1/2023 TD Cowen
» Updated 8/1/2023		 Tyler Van Buren Downgrade Hold
(Buy)		 172.50
(140.00)		 167.19
(172.36)		 3.09% Details
7/31/2023 Barclays Carter Gould Downgrade Equalweight
(Overweight)		 172.00
(N/A)		 167.19
(172.36)		 3.09% Details